Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14436
Articles
Company
Deals
Topchoice Medical to Acquire 19% Stake in Heren Health for $72.2M
January 16, 2025
Company
Deals
Eluminex Biosciences Closes $40M Series B for Ophthalmic Innovations
January 16, 2025
Company
Deals
RinuaGene Raises $14.4M in Pre-Series A+ for mRNA Drug Development
January 16, 2025
Company
Junshi Biosciences Reports 2022 Preliminary Earnings with Revenue Decline
January 16, 2025
Company
Deals
Chipscreen Biosciences Licenses First-in-Class BsAb YH008 from Eucure
January 16, 2025
Company
Drug
Novartis’ LNP023 and Janssen’s Tremfya on Track for Breakthrough Designations
January 16, 2025
Company
Deals
Suzhou Porton Biologics Partners with CorrGene for Cell and Gene Therapy
January 16, 2025
Company
Drug
Sanofi’s Sarclisa Approved for Import in Shenzhen via Greater Bay Area Scheme
January 16, 2025
Company
Drug
Innovent Biologics Begins Phase I Trial for IBI333 in Neovascular AMD
January 16, 2025
Company
Drug
Hybio’s COVID-19 Nasal Spray HY3000 Gets FDA Clinical Trial Approval
January 16, 2025
Company
Drug
Junshi Biosciences’ PCSK9 Inhibitor Ongericimab Meets Phase III Endpoints
January 16, 2025
Company
Deals
Oricell Therapeutics Closes $45M Series B1 Round for Cellular Immunotherapy
January 16, 2025
1
2
…
1,022
1,023
1,024
1,025
1,026
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?